Skip to main content

Select Drug Profiles

Adverse Events Reporting in Oncology Studies Suboptimal

Ibrutinib Approved for Chronic Lymphocytic Leukemia

Tafinlar Receives Breakthrough Therapy Designation for Lung Cancer

Hematologists Often Ignore Treatment and Monitoring Recommendations

Caroline Helwick

Leukemia, Oncology

Promising Drugs in the Pipeline for Leukemia and Myelodysplastic Syndromes

Decitabine More Cost-Effective than Conventional Induction in Older Patients with AML

New Directions in the Treatment of Multiple Myeloma: Reports on Carfilzomib Therapy from the 2013 Annual Meeting of the American Society of Hematology

“I Have a Hunch”

David B. Nash, MD, MBA

Practice Management

Resource Utilization and Cost in a Commercially Insured Population with Schizophrenia

Kathryn Fitch, RN, MEd, Kosuke Iwasaki, FIAJ, MAAA, Kathleen F. Villa, MS

Stakeholder Perspective

Schizophrenia: “The Forgotten Illness”?

by Atheer A. Kaddis, PharmD

Original Research

Fixed-Dose Combination Gel of Adapalene and Benzoyl Peroxide plus Doxycycline 100 mg versus Oral Isotretinoin for the Treatment of Severe Acne: Efficacy and Cost Analysis

Pete Penna, PharmD, Matthew H. Meckfessel, PhD, Norman Preston, PhD

Stakeholder Perspective

Evaluating Treatments for Acne: It’s Time to “Sweat” the Smaller Things

by Gary M. Owens, MD

Page 160 of 244
Results 1591 - 1600 of 2438